Sun Pharma share price falls on settlement order by SEBI, here is what brokerages have to say

Research house Macquarie has kept outperform rating with a target at Rs 700.

Buy Sun Pharmaceutical Industries; target of Rs 700: Sharekhan

Sharekhan is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 700 in its research report dated January 29, 2021.

Sun Pharma recalls 36,275 cartons of testosterone injection in the US for labelling error

The US arm of the domestic pharma major is recalling Testosterone Cypionate Injection in the American market, according to the latest enforcement report of the US Food and Drug Administration.

Buy Sun Pharmaceutical Industries; target of Rs 672: Prabhudas Lilladher

Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 672 in its research report dated February 01, 2021.

Buy Sun Pharmaceutical Industries; target of Rs 675: ICICI Direct

ICICI Direct is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 675 in its research report dated January 31, 2021.

Hold Sun Pharmaceutical Industries; target of Rs 602: Prabhudas Lilladher

Prabhudas Lilladher recommended hold rating on Sun Pharmaceutical Industries with a target price of Rs 602 in its research report dated January 28, 2021.

Sun Pharma Consolidated December 2020 Net Sales at Rs 8,836.78 crore, up 8.36% Y-o-Y

Sun Pharma Standalone December 2020 Net Sales at Rs 3,388.02 crore, up 12.43% Y-o-Y

Buy Sun Pharmaceutical Industries: target of Rs 660 : Sharekhan

Sharekhan is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 660 in its research report dated December 14, 2020.

Buy Sun Pharmaceutical Industries; target of Rs 585: ICICI Direct

ICICI Direct is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 585 in its research report dated November 04, 2020.

Buy Sun Pharmaceutical Industries; target of Rs 597: Prabhudas Lilladher

Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 597 in its research report dated November 04, 2020.

Buy Sun Pharmaceutical Industries: target of Rs 612: Sharekhan

Sharekhan is bullish on Sun Pharmaceutical Industries recommended buy rating on the stock with a target price of Rs 612 in its research report dated November 03, 2020.

Sun Pharma Consolidated September 2020 Net Sales at Rs 8,553.13 crore, up 5.29% Y-o-Y

Reduce Sun Pharmaceutical Industries; target of Rs 476: Prabhudas Lilladher

Prabhudas Lilladher recommended Reduce rating on Sun Pharmaceutical Industries with a target price of Rs 476 in its research report dated October 30, 2020.

Sun Pharma Q2 earnings beat the Street as profit surges 70% to Rs 1,813 crore

Consolidated revenue from operations grew by 5.3 percent year-on-year to Rs 8,553 crore in September quarter.

Sun Pharma Q2 preview: Taro may hit revenue growth, trends in specialty portfolio key to watch

Sun Pharma's key facility Halol continues to be under FDA issue which has slowed down new approvals.

Sun Pharma share price rises 2% on launch of ILUMYA in Japan

The company's wholly-owned Japanese subsidiary has launched ILUMYA Subcutaneous Injection 100 mg Syringe in Japan.

Buy Sun Pharmaceutical Industries; target of Rs 625: ICICI Direct

ICICI Direct is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 625 in its research report dated August 02, 2020.

Reduce Sun Pharmaceutical Industries; target of Rs 479: Prabhudas Lilladher

Prabhudas Lilladher recommended reduce rating on Sun Pharmaceutical Industries with a target price of Rs 479 in its research report dated August 02, 2020.

Hold Sun Pharmaceutical Industries; target of Rs 479: Prabhudas Lilladher

Prabhudas Lilladher recommended Hold rating on Sun Pharmaceutical Industries with a target price of Rs 479 in its research report dated July 31, 2020.

Sun Pharma Consolidated June 2020 Net Sales at Rs 7,585.25 crore, down 9.42% Y-o-Y

Sun Pharma Standalone June 2020 Net Sales at Rs 2,963.04 crore, down 10.46% Y-o-Y

Sun Pharma share price hits 52-week high post June quarter earnings

Net profit before one-time loss stood at Rs 1,449.4 crore, which grew by 4.5 percent on year-on-year basis.

Sun Pharma posts Q1 loss Rs 1,655.6 crore on one-time loss, but operating numbers beat estimates

The company had reported a net profit of Rs 1,387.5 crore in the corresponding quarter a year ago.

Rakesh, Rekha Jhunjhunwala acquire 3.2% stake in Dishman, Vijay Kedia buys shares in Ramco in Q1 FY21

Life Insurance Corporation raised its stake in Godrej Industries to 3.87 percent in June quarter from 3.7 percent in the March quarter